GR3003657T3 - - Google Patents

Info

Publication number
GR3003657T3
GR3003657T3 GR920400086T GR920400086T GR3003657T3 GR 3003657 T3 GR3003657 T3 GR 3003657T3 GR 920400086 T GR920400086 T GR 920400086T GR 920400086 T GR920400086 T GR 920400086T GR 3003657 T3 GR3003657 T3 GR 3003657T3
Authority
GR
Greece
Prior art keywords
compound
antidepressive
agent containing
synergistic activity
synergistic
Prior art date
Application number
GR920400086T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3003657T3 publication Critical patent/GR3003657T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dental Preparations (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
GR920400086T 1987-02-27 1992-01-27 GR3003657T3 (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873706399 DE3706399A1 (de) 1987-02-27 1987-02-27 Mittel mit antidepressiver wirkung

Publications (1)

Publication Number Publication Date
GR3003657T3 true GR3003657T3 (OSRAM) 1993-03-16

Family

ID=6321945

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920400086T GR3003657T3 (OSRAM) 1987-02-27 1992-01-27

Country Status (14)

Country Link
US (2) US4931435A (OSRAM)
EP (1) EP0280290B1 (OSRAM)
JP (1) JPS63238019A (OSRAM)
KR (1) KR880009647A (OSRAM)
AT (1) ATE71300T1 (OSRAM)
AU (1) AU605554B2 (OSRAM)
CA (1) CA1317229C (OSRAM)
DE (2) DE3706399A1 (OSRAM)
DK (1) DK102988A (OSRAM)
GR (1) GR3003657T3 (OSRAM)
HU (1) HU200919B (OSRAM)
IL (1) IL85560A (OSRAM)
NZ (1) NZ223670A (OSRAM)
ZA (1) ZA881366B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3386500A (en) 1999-03-02 2000-09-21 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
AU3389300A (en) * 1999-03-02 2000-09-21 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
US6489354B1 (en) 1999-03-02 2002-12-03 Merck & Co., Inc. 3-alkyl substituted pyrrolidine modulators of chemokine receptor activity
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3301759A (en) * 1965-05-26 1967-01-31 Robins Co Inc A H Analeptic compositions and method
CA1115212A (en) * 1978-02-10 1981-12-29 Emilio Kyburz Pyrrolidine derivatives
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
HU200919B (en) 1990-09-28
ZA881366B (en) 1989-10-25
ATE71300T1 (de) 1992-01-15
IL85560A (en) 1991-12-12
IL85560A0 (en) 1988-08-31
KR880009647A (ko) 1988-10-04
NZ223670A (en) 1990-12-21
JPS63238019A (ja) 1988-10-04
EP0280290A3 (en) 1989-08-09
DK102988A (da) 1988-08-28
CA1317229C (en) 1993-05-04
DK102988D0 (da) 1988-02-26
EP0280290B1 (de) 1992-01-08
DE3867501D1 (de) 1992-02-20
AU605554B2 (en) 1991-01-17
EP0280290A2 (de) 1988-08-31
AU1235288A (en) 1988-09-01
HUT46535A (en) 1988-11-28
US4931435A (en) 1990-06-05
US5217967A (en) 1993-06-08
DE3706399A1 (de) 1988-09-08

Similar Documents

Publication Publication Date Title
CS103687A2 (en) Antifugi agent for wood
AU577862B2 (en) Synergistic fungicidal agents
EP0280290A3 (en) Agent having an antidepressive activity
DE3872752D1 (en) Isolator.
EP0311864A3 (en) Machine-tool
EP0309893A3 (en) Insecticidal agent
ZA883808B (en) Active compounds
RO102645B1 (en) Synergistic herbicidal composition
GB2205057B (en) Workpiece securing and locating arrangement.
CS453887A1 (en) Biocide agent
CS85488A1 (en) Carburizing agents
GB8628357D0 (en) Chelating agents synergistic treatment
GB8711273D0 (en) Antimicrobial agents
PL263127A1 (en) Microbe killing agent
GB8730045D0 (en) Active compounds
GB8716375D0 (en) Active compounds
GB8730044D0 (en) Active compounds
GB8730048D0 (en) Active compounds
GB8720946D0 (en) Active compounds
GB8710426D0 (en) Active compounds
GB8730047D0 (en) Active compounds
GB8730046D0 (en) Active compounds
GB8725058D0 (en) Active compounds
GB8730053D0 (en) Active compounds
GB8729365D0 (en) Active compounds